<code id='FC4140AC92'></code><style id='FC4140AC92'></style>
    • <acronym id='FC4140AC92'></acronym>
      <center id='FC4140AC92'><center id='FC4140AC92'><tfoot id='FC4140AC92'></tfoot></center><abbr id='FC4140AC92'><dir id='FC4140AC92'><tfoot id='FC4140AC92'></tfoot><noframes id='FC4140AC92'>

    • <optgroup id='FC4140AC92'><strike id='FC4140AC92'><sup id='FC4140AC92'></sup></strike><code id='FC4140AC92'></code></optgroup>
        1. <b id='FC4140AC92'><label id='FC4140AC92'><select id='FC4140AC92'><dt id='FC4140AC92'><span id='FC4140AC92'></span></dt></select></label></b><u id='FC4140AC92'></u>
          <i id='FC4140AC92'><strike id='FC4140AC92'><tt id='FC4140AC92'><pre id='FC4140AC92'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:51145
          Cynthia Fisher on stage at the 2023 STAT Summit.
          Cynthia Fisher, founder and chairman, PatientRightsAdvocate.org STAT

          BOSTON — For all those who think hospital price transparency will not save money, Cynthia Fisher has a message: it’s already doing so.

          Fisher, who spoke Wednesday at the annual STAT Summit in Boston, is the successful entrepreneur and founder of PatientRightsAdvocate.org who has been leading an unorthodox campaign to get hospitals to disclose prices.

          advertisement

          The campaign has made progress. Republicans on three House committees introduced a bill to make hospitals disclose prices up front, though then-House Speaker Kevin McCarthy (R-Calif.) pulled the bill shortly before it was supposed to receive a vote on the House floor.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO
          The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

          MollyFerguson/STATHappyGroundhogDayeve.SometakesandthoughtsonBluebirdBio’squestforgenetherapyprofits

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Achieving telehealth equity for people with hearing loss

          AdobeGenZhasmadecaptioningcool.Captionsarenowwidelyavailableinsocialmedia,entertainmentchannels,andw